Navigation Links
Fly Ash Bricks are Absolutely Safer Than Actually Predicted

A new study by an American researcher has revealed that bricks made from fly-ash particles captured as waste by coal-fired power plants might be safer than predicted.

Rather than leach minute amounts of mercury as some researchers had predicted, the bricks do the reverse, pulling minute amounts of the toxic metal out of ambient air.

New experiments by Henry Liu, a longtime National Science Foundation (NSF) awardee and the president of Freight Pipeline Company (FPC), which developed the bricks, has revealed that fly ash bricks help lower the concentration of toxic materials in enclosed air.

On average, air contains low amounts of mercury that can range from less than one nanogram per cubic meter (ng/m3) to tens of ng/m3--a small fraction of the Environmental Protection Agency limit for continuous exposure.

Liu found that inside a confined experimental chamber, the bricks did not raise the mercury levels in the surrounding air (originally more than one nanogram).

Instead they appeared to lower the concentration down to roughly half a nanogram.

According to Tom Allnutt, who oversaw Lius NSF's Small Business Innovation Research (SBIR) program award, fly ash bricks could offset the environmental impact from the manufacture of standard bricks through fire-powered kilns.

"Green manufacturing is a focus for the nation. Liu's innovative use of fly ash to manufacture high quality building materials will potentially decrease some of the negative environmental impact of coal-fired power generation while meeting increasing demands for greener building materials, Allnutt said.

"Manufacturing clay brick requires kilns fired to high temperatures. That wastes energy, pollutes air and generates greenhouse gases that contribute to global warming. In contrast, fly ash bricks are manufactured at room temperature. They conserve energy, cost less to manufacture, and don't contr
'"/>




Page: 1 2

Related medicine news :

1. Heart Surgery Is Getting Safer for the Old
2. Estrogen Patch is Safer than Pills for Heart
3. Traffic Violations Result in Safer Drivers
4. British company developing ‘Safer Cigarettes
5. Surgery Simulators Offer Better Surgeons And Safer Surgeries
6. Mapping Of Brain Highly Beneficial For Safer Brain Tumor Surgery
7. Doppler USG-Safer Technique For Detection Of Rh Diseases In Fetus
8. Enbrelr Enters Safer Zone After Recent Research
9. Child-Proof: Brain Mapping Safer for Children than Previously Thought
10. Laser Surgery Safer Than Contact Lenses?
11. Consumers, Caregivers Taking Steps to Safer Surgery
Post Your Comments:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4